Danya Qato, PhD, PharmD, MPH, is an associate professor in the Department of Practice, Sciences, and Health Outcomes Research (P-SHOR) and graduate program director of Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy
Dr. Danya M. Qato is a practicing pharmacist, epidemiologist, and health services researcher. She holds a PhD in health and pharmaceutical services research from the Brown University School of Public Health, a Doctor of Pharmacy (PharmD) from the University of Illinois, and a Master of Public Health (MPH) with a concentration in international health and humanitarian studies from Harvard University. In 2020, she was selected as a Robert Wood Johnson Foundation Culture of Health Leader.
Her research is currently funded by the National Institute on Aging, the Food and Drug Administration, and the Institute for Clinical and Translational Research. At Brown, Dr. Qato was funded as an Agency for Healthcare Research and Quality and National Institutes of Health doctoral and postdoctoral research fellow in comparative effectiveness research.
Dr. Qato’s substantive areas of research pertain to improving regulatory and policy tools to reduce use of high risk medications in vulnerable populations, substance use and women’s health, risk management and post-marketing surveillance, drug pricing and access to essential medicines, environmental and global health systems development, pharmacovigilance, and global health equity. She was previously a Schweitzer Fellow, a Paul and Daisy Soros Fellow (for support of her MPH at Harvard), and a U.S. research fellow of the Palestinian American Research Center (PARC) and the Arab Council for the Social Sciences funded by the Swedish International Development Agency. In the 2015-2016 academic year, Dr. Qato was based at the Institute for Community and Public Health at Birzeit University in Palestine, where she was a Fulbright Scholar and served as an expert consultant to the World Health Organization. In addition to her role as an assistant professor in the Department of Pharmaceutical Health Services Research (PHSR), Dr. Qato holds a secondary appointment in the University of Maryland School of Medicine, Department of Epidemiology and Public Health, is a faculty affiliate at the University of Maryland Institute for Global Health, and a faculty member of the joint UMB/UMBC PhD Program in Gerontology. She is former chair of the Drug Policy and Pharmaceutical Services Committee of the Medical Care Section of the American Public Health Association and is a member of the Public Health subcommittee of the Maryland State Taskforce on Reconciliation and Equity.
Current funding as Principal Investigator:
Food and Drug Administration funded (7/1/2020-present): Data-informed Models to Identify Optimal Opioid Use Disorder Treatment Trajectories
Danya M. Qato, PhD, PharmD, MPH
Associate Professor of Practice, Sciences, and Health Outcomes Research
Graduate Program Director of Pharmaceutical Health Services Research
University of Maryland School of Pharmacy
220 Arch Street, 12th Floor
Baltimore, MD 21201
Office: (410) 706-4044